Health
STAT+: Pharmalittle: We’re reading about AstraZeneca cost-cutting, Sun Pharma facility problems, and more
AstraZeneca has launched a three-year cost-cutting program that aims to slice off $1.5 billion a year, with the savings reinvested in R&D
- Published
- (51 min ago)
- Outlet
- STAT News
- Section
- Health
- Length here
- Headline and 22-word snippet. The full article is at the source.
More from STAT News and around the same time
How Election Day can affect your heartPolitical campaigns can do more than raise your blood pressure. Studies link election stress to irregular heartbeats and an increase in heart attacks.Assessing Merck and Moderna’s mRNA cancer vaccineOn this week's “The Readout LOUD,” we discuss the latest cancer data presented at the annual meeting of the European Society for Medical Oncology.The persisting paradox of men’s healthA new series in The Lancet argues for the need to investigate a paradox of men’s health: why men experience worse health outcomes than women, even though they hold undeniable…Opinion: How Congress can fix expert advisory committees“This evisceration of scientific advice is untenable,” write C. Joseph Ross Daval and Aaron S. Kesselheim.Opinion: What a mother’s 1834 letter about measles tells us about MAHAAn 1834 letter about a measles outbreak sheds light on today’s anti-vaccine movement, writes a medical historian.STAT+: FDA, CMS scramble to avoid regulatory logjam as more states look to test AI in clinical settingsOfficials are moving behind the scenes to head off a conflict brewing between states and the federal government over regulating AI.This page holds the headline and a short snippet as published by STAT News, whose feed they came from. The story itself, the photography and the rights stay with them, and the button above goes straight to their site. We keep this page so the headline has a stable address and a record of when it ran.
